Search: 2018 EU Meeting Attendees
Results 1 - 16 of 16

Neil Venn

Associate Scientific Director
Prime Global

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
Other Degrees*: MRes, BSc
CMPP Certified: (3/2017)

Anne Clare Wadsworth

Global Business Unit Head
Envision Pharma

Bio: Anne Clare brings a wealth of experience in healthcare communications from a 20 year career leading medical strategy and communication agencies. With a focus on innovation, Anne Clare has been at the forefront of transforming agency services, reflecting the ever-changing requirements of Medical Affairs and Publications teams within biopharmaceutical companies. Beginning her agency career at Gardiner-Caldwell Communications in 2000, Anne Clare supported clients across multiple therapy areas and product launches prior to joining Envision Pharma Group in 2016 as part of the senior leadership team. With a keen interest in patient engagement, Anne Clare has been a vocal advocate for tackling the lack of consistent and evidence-based practices for patient partnership within life science communications as well as exploring how patient advocates and medical affairs teams can work in partnership towards shared goals. Last year, Anne Clare in partnership with her colleague Professor Karen Woolley, launched a new centre of excellence within Envision Pharma Group dedicated to Patient Partnership in Medical Affairs and Publications. Comprising a team of industry experts, the Envision the Patient team are leading the industry debate on the removal of barriers for patients wanting access to high quality, fair-balance scientific content.

Joanne Walker

Head of Publishing Solutions, Business Development
Future Science Group

Type of Company:
Professional Degrees: BA/BS

Steven Walker

Director and Co-Owner
St Gilesmedical London & Berlin

Type of Company:
Communications Agency
Professional Degrees: MD, MEd, MS
CMPP Certified: (3/2016)

Bio: Steven has degrees in medicine, education and clinical oncology. He trained in the UK, USA and Germany. His focus is on building St Gilesmedical's team of medics, scientists, writers and educators in London and Berlin into a major health communication company. Current interests include medical and regulatory writing, teaching and delivery of effective meetings. Steven is active in ISMPP, EMWA and lectures at Manchester Metropolitan University. St Gilesmedical also supports non-commercial education and research activities in the UK and Germany. The needs of patients and healthcare professionals are at the centre of everything we do.

James Wallis

Publications Manager
Cello Health Communications

Type of Company:
Communications Agency

Alice Wareham

Senior Medical Writer
Aspire Scientific Ltd

Type of Company:
Professional Degrees: BA/BS, CMPP, MS, PhD
CMPP Certified: (9/2018)

Carolyn Watson

Director, Scientific Publications & Knowledge Services

Type of Company:
Professional Degrees: BA/BS, PhD

Peter Weber

Managing Director, German Operation
Content Ed Net GmbH

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2011)

Richard White

Chief Operating Officer
Oxford PharmaGenesis Ltd

Type of Company:
Communications Agency
Professional Degrees: MA, PhD

Bio: Richard White is Chief Operating Officer at Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 20 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, and has personally authored more than 20 journal publications. Richard has published white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, is an invited author of articles for ISMPP's MAP e-newsletter, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice and communications expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies and academic institutions, and has delivered invited presentations, educational webinars and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP and TIPPA Annual Meetings, the World Orphan Drug Congress, and the Patient Summit. Richard was Chair of the 2017 and 2018 TIPPA Annual Meetings. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator's Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is a member of Green Templeton College, University of Oxford, UK.

Witold Wiecek

Statistical Project Manager
Analytica Laser

Bio: Witold Wiecek, is a Statistical Project Manager at Analytica Laser, Witold is currently a technical lead for HOPE: LASER's proprietary tool for modelling real-world effectiveness, as well as working and publishing on Bayesian inference models, survival analysis, network meta-analyses, and infectious disease modelling.

Jurgen Wiehn

Senior Director, Medical Affairs
Avexis GmbH

Type of Company:
Professional Degrees: CMPP, PhD
CMPP Certified: (9/2011)

Bio: Jurgen, PhD, ISMPP CMPP, has over 15 years of international pharmaceutical/biotech experience in medical affairs and clinical development (Publications/Scientific and Regulatory Writing; Medical Information, Communication and Education). Prior to industry career, Jurgen studied biology, gained his PhD in Finland and lead academic research programs in Finland and Switzerland. His industry experience comes from Orion Pharma, Merck Serono, Ferring Pharmaceuticals, Shire and, most recently, from Shire, where Jurgen works as a Senour Director, EMEA Medical Communications and Publications since 2018.

David Williams

Global engagement lead Real World Data and Analytics

Bio: David is a physician with 10 years' clinical experience in primary and secondary care in the UK and Australia, as well as over 17 years as a pharmaceutical physician with a specific interest in the medical role in health policy and market access. David has provided medical leadership in numerous launch teams, lead successful HTA submissions and has a wide therapeutic experience. In addition to 12 years of medical roles including regional and affiliate level leadership roles, he has also roles in as Head of HEOR for Global R&D AstraZeneca as well as Global Head of Government Affairs in AZ. In addition to his medical degree, David is also a Masters graduate in Heath Economics and Evidence-Based Medicine. David joined Sanofi in 2015 as Medical Director and then Country Medical Chair in the UK & Ireland, and since April 2016 has been Global Head of Medical Education and Scientific Communications reporting to Dr Sandra Silvestri in GEM. He has been married to Ruth for 25 years and they have two sons: Felix and Seth.

Christopher Winchester

Chief Executive Officer
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Chief Executive Officer of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 21st year, Oxford PharmaGenesis employs over 250 communications professionals in Europe, North America and Asia Pacific. Chris is Chair of ISMPP, a founder of Open Pharma, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College at the University of Oxford.

Steve Winter

Global Publications Leader, Global Medical Affairs

Type of Company:
Professional Degrees: PhD
Other Degrees*: BPharm
CMPP Certified: (3/2016)

Bio: Steve is a former pharmacist, with a PhD in cardiovascular pharmacology (University of Bath, UK). Having completed his academic studies, Steve commenced his career in medical communications, first within the agency sector and most recently with various pharmaceutical and diagnostic/device companies in Switzerland and the UK. He is currently Global Publications Leader for AstraZeneca (UK). Steve obtained his CMPP certification in March of 2016.

Karen Woolley

Global Lead, Patient Partnerships
ProScribe - Envision Pharma Group

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2010)

Bio: Professor Karen Woolley is Certified Medical Publication Professional. She has 25 years of experience in the healthcare sector, gained in academia, hospital, industry, and agency environments in North America and the Asia Pacific region. She has led international teams to conduct and publish research on publication ethics and on patient engagement in evidence generation and communication. In 2000, Karen co-founded the Asia Pacific medical communication agency, ProScribe, which is proudly part of the global Envision Pharma Group. She has a strong focus on strategic initiatives in the medical affairs sector and leads teams in Envision's Tokyo and Sydney offices. Karen has served on ISMPP's Board of Trustees, chaired ISMPPs Asia Pacific Advisory Committee, and co-authored the Good Publication Practice 3 guidelines and the Joint Position Statement on Professional Medical Writers. She is an Honorary Fellow of AMWA, a Life Member of ARCS, and initiated the Global Alliance of Publication Professionals. She is a Professor at two universities and has been a government-appointed director overseeing 6 hospitals, serving on the Patient Safety and Quality Committee, and managing a $2B budget.

Josie Wyss

MRS/ Global Clinical Affairs
Cochlear Ltd.